FibroBiologics wins European patent for methods to enhance fibroblast regenerative activity

The patent covers conditioning fibroblasts with platelet-rich plasma, including cytokines such as FGF-alpha or FGF-beta, and provides protection for angiogenesis-related applications and spinal disc regeneration. FibroBiologics says the grant expands a portfolio of more than 270 issued or pending patents across fibroblast-based therapies.